Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
clinical trials
3
×
life sciences
national blog main
amgen
boston top stories
cancer
cancer drugs
eli lilly
fda
indiana blog main
indiana top stories
ipo
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
adaptive biotechnologies
alector
allergan
alprazolam
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cgrp inhibitors
chronic migraine
civica rx
colorectal cancer
colucid pharmaceuticals
deals
detroit blog main
detroit top stories
diabets
What
pharmaceutical
3
×
cancer
eli
giant
acute
addresses
appetite
approval
bio
black
bread
butter
buyout
cancer’s
cash
causes
condition
decades
diabetes
diamond’s
disease
drug
drugs
fda
friday
frontiers
giving
grabbed
hasn’t
hold
ipo
known
lasmiditan
lilly
lilly's
lilly’s
lost
loxo
maps
medication
Language
unset
Current search:
pharmaceutical
×
" boston blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More